By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pressure BioSciences has raised $500,000 in the second tranche of its $2.5 million Series B private placement.

The South Easton, Mass.-based firm sold units at $18.80 each. The units consisted of one share of non-voting Series B Convertible Preferred Stock, and one warrant to purchase a share of Series B Convertible Preferred Stock at an exercise price of $28.80 per share, expiring on Aug. 11, 2011.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.